Results 21 to 30 of about 82,474 (317)
Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients [PDF]
The Korean Journal of Internal Medicine, 2021 Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease 1 (PKD1) and
Yun Kyu Oh +4 more
doaj +1 more source
Diagnostics, 2023 Background: We aimed to investigate the association between kidney stones and polycystic ovarian syndrome (PCOS). Materials and methods: In a cross-sectional study, data from the Tehran Lipid and Glucose Study (TLGS) were used to investigate the risk of ...
Marzieh Rostami Dovom +5 more
doaj +1 more source
Polycystic Kidney Disease [PDF]
Journal of the American Society of Nephrology, 2007 Renal cysts are common clinical findings, often incidentally discovered in the course of evaluating other problems. They may be either acquired or seen in association with a number of inherited and congenital disorders. The most common disorder, autosomal dominant polycystic kidney disease (ADPKD), is an important cause of end-stage renal disease (ESRD)
Stefan Somlo, Peter Igarashi
openaire +2 more sources
Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury [PDF]
, 2009 Autosomal dominant polycystic kidney disease (ADPKD) results from mutations in either PKD1 or PKD2 and accounts for 10% of all patients on renal replacement therapy. The kidney disease phenotype is primarily characterized by cyst formation, but there are
Haylor, J.L. +4 more
core +2 more sources
Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy. [PDF]
PLoS ONE, 2015 Autosomal recessive polycystic kidney disease is a truly catastrophic monogenetic disease, causing death and end stage renal disease in neonates and children.
K J Kelly +6 more
doaj +1 more source
Polycystic Kidney Disease [PDF]
Pediatrics In Review, 2009 1. Jacques Benun, MD 2. Carol Lewis, MD 1. Hasbro Children's Hospital Providence, RI Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): The New Horizon For Children Who Have DPKD . Rizk D, Chapman A. Pediatr Nephrol. 2008;23 :1029– 1036[OpenUrl][1][CrossRef][2][PubMed][3] Autosomal Recessive Polycystic Kidney Disease ...
Carol Lewis, Jacques Benun
+9 more sources
p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. [PDF]
, 2007 BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease with few treatment options other than renal replacement therapy. p21, a cyclin kinase inhibitor which has pleiotropic effects on the cell cycle, in many cases acts
Anderson, Sharon +6 more
core +3 more sources
Molecular Mechanisms of Isolated Polycystic Liver Diseases
Frontiers in Genetics, 2022 Polycystic liver disease (PLD) is a rare autosomal dominant disorder including two genetically and clinically distinct forms: autosomal dominant polycystic kidney disease (ADPKD) and isolated polycystic liver disease (PCLD).
Ziqi Yu +5 more
doaj +1 more source
Polycystic horseshoe kidney [PDF]
Medical Journal Armed Forces India, 2015 Polycystic kidney disease (PKD) is a hereditary disorder of autosomal dominant or recessive inheritance. Horseshoe kidney is a common renal fusion anomaly during embryogenesis. Combination of both PKD and horseshoe kidney is rare, with an incidence of one in 1,34,000–8,00,000 live births.1 Less than twenty cases have been reported till date in adults ...
Mahadev N. Honawad +3 more
openaire +3 more sources
Kidney Medicine, 2023 Rationale & Objective: The development of new therapies for autosomal dominant polycystic kidney disease requires clinical trials to be conducted efficiently. In this study, the factors affecting the recruitment and retention of participants enrolled
Sneha Amin +23 more
doaj